News Center

Home page

Peak Report

News reports

Sales of summer heat prevention drugs in large pharmacies increased significantly

Release time:

2022-08-24

News from our newspaper # The high temperature continued after February, which is the peak season for sales of heatstroke prevention and cooling drugs. Peak pharmacies seized the opportunity to actively expand group buying customers, with significant year-on-year growth in the number of customers and sales.

Since the new crown epidemic, store epidemic prevention requirements are strict, customers need to enter the store multiple steps, coupled with four categories of drug sales restrictions, retail pharmacy business has generally been affected. In the face of difficulties, Jianfeng Pharmacy has actively explored its ideas and looked for sales growth points. From July , it has carefully selected the categories of heatstroke prevention drugs and has planned stock to ensure sufficient supply of goods and drugs in summer, so as to purchase a variety of varieties and varieties. Each category is equipped with multiple manufacturers, high, medium and low prices, for different customers to choose according to their respective situations.

The summer weather this year was sultry. There was no continuous precipitation after entering the plum. The high temperature weather started early and lasted for a long time. The heatstroke prevention and cooling drugs were popular. Jianfeng Pharmacy maintains old customers and develops new customers. Actively contact customers with more outdoor operations such as logistics and construction and more high-temperature workers; Actively participate in the bidding for heatstroke prevention drugs and group buying products. Fang Yanfei, manager of Shuangxi Store, who is responsible for contacting customers, said that the sales are mainly small group purchases, with a relatively small total amount and a large number of customers. According to the working characteristics and budget of different customers, drug combinations with different prices have been prepared. Each drug has been compared with other merchants in advance to set a reasonable price and improve the success rate of group purchases. In summer, many pharmacies are competing for the group purchase business of heatstroke prevention drugs. Some customers communicated four or five times and discussed it for a long time. Through hard work, the number of customers of group purchase of heatstroke prevention drugs increased from

11 in the same period last year to 20 enterprises and institutions, with sales increasing by 209% year on year.

After the group purchase is negotiated, the business department will quickly transfer the goods according to the customer's demand to ensure timely supply. Among the heatstroke prevention drugs, liquid drugs such as Huoxiang Zhengqi water account for a large proportion. When delivery, customers have to be moved into warehouses, and some have to be transported upstairs. Most pharmacies are female employees, but everyone still overcomes difficulties and provides customers with the best quality. service. In addition to the group buying business, each store also has a variety of products for customers to buy in the store.

Summer heatstroke prevention drug group purchase has increased, but it belongs to seasonal sales, the total amount is relatively small, and the gross profit of some drugs is low. In the future, the peak pharmacy will adjust its sales focus in due course, strengthen the sales of tonic drugs in autumn and winter, and intensify its efforts to build a famous doctor of traditional Chinese medicine. Continuously improve the product structure, implement

"one product with multiple regulations" in each store, and implement multi-manufacturer, multi-grade and multi-specification matching to promote sales of products with large sales volume; We should dig new growth points from multiple angles and seek ways to "break the game. (Reporter

Chen Shengmu)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页